You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

showing PET positive residual lesions

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FES F18 PET/CT in Metastatic Breast Cancer Patients

Recruiting
  • Metastatic Breast Cancer
  • 18F Fluoroestradiol Radiopharmaceutical with PET/CT
  • Long Beach, California
  • +5 more
Jan 19, 2023

Metastasis From Malignant Tumor of Prostate (Disorder) Trial in United States (64Cu-PSMA I&T)

Recruiting
  • Metastasis From Malignant Tumor of Prostate (Disorder)
  • 64Cu-PSMA I&T
  • New Haven, Connecticut
  • +7 more
Jan 17, 2023

Breast Cancer, HER2-positive Breast Cancer Trial in São Paulo (PHESGO)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • São Paulo, Brazil
    Centro Paulista de Oncologia (Oncoclínicas)
Oct 3, 2023

Brain Metastases Trial in Tucson (18F-Fluciclovine PET/CT)

Not yet recruiting
  • Brain Metastases
  • 18F-Fluciclovine PET/CT
  • Tucson, Arizona
    Arizona Cancer Center at UMC North/University Medical Center
Sep 20, 2023

SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)

Recruiting
  • SSTR2
  • +2 more
  • 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
May 24, 2023

Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)

Terminated
  • Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
  • Badalona, Barcelona, Spain
  • +11 more
Jul 26, 2022

68-Ga DOTATATE PET/MRI in Diagnosis and Management of

Recruiting
  • CNS Tumors
  • +6 more
  • Ga68-DOTATATE-PET/MRI
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)

Not yet recruiting
  • HER2-positive Breast Cancer
  • 68Ga/131I-SGMIB-5F7
  • Shanghai, China
    Huashan Hospital
Aug 1, 2023

Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)

Active, not recruiting
  • Advanced Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +6 more
  • Antwerp, Belgium
  • +18 more
May 4, 2022

Acute Coronary Syndrome, Atherosclerosis, Inflammation Trial in Bologna (coronary OCT, 68GaDOTATATE PET/CTCA)

Recruiting
  • Acute Coronary Syndrome
  • +3 more
  • coronary OCT
  • 68GaDOTATATE PET/CTCA
  • Bologna, Italy
    University of Bologna IRCCS Policlinico di St. Orsola
Jun 27, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Multiple Myeloma Trial in Nantes ([68Ga]Ga-PentixaFor)

Not yet recruiting
  • Multiple Myeloma
  • Nantes, France
    CHU de Nantes
Apr 4, 2022

Brain Metastases Trial in Houston (18F-Fluciclovine (Axumin), Pet Scan)

Not yet recruiting
  • Brain Metastases
  • 18F-Fluciclovine (Axumin)
  • Pet Scan
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and

Not yet recruiting
  • Von Hippel-Lindau Disease
  • 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
  • (no location specified)
Mar 30, 2023

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

HER2 Positive or Suspicious Positive Tumors Trial in Beijing (68Ga/18F-HER2 Affibody PET/CT scan)

Recruiting
  • HER2 Positive or Suspicious Positive Tumors
  • 68Ga/18F-HER2 Affibody PET/CT scan
  • Beijing, Beijing, China
    Hua Zhu
Jul 18, 2022

Breast Cancer Trial in Switzerland (Vacuum assisted biopsy (VAB))

Recruiting
  • Breast Cancer
  • Vacuum assisted biopsy (VAB)
  • Aarau, Switzerland
  • +15 more
Jan 10, 2023

Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)

Not yet recruiting
  • Prostate Cancer
  • Localized Prostate Carcinoma
  • PSMA-1007 Positron Emission Tomography (PET) scan
  • (no location specified)
Aug 14, 2023

Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

Active, not recruiting
  • Breast Cancer
  • +11 more
  • radionuclide imaging
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Oct 20, 2022

Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer Trial in France (SRT, Immunotherapy)

Recruiting
  • Locally Advanced Non Small Cell Lung Cancer
  • Metastatic Non Small Cell Lung Cancer
  • Angers, France
  • +4 more
Apr 21, 2022

Diffuse Large B-cell Lymphoma Trial in Switzerland (Acalabrutinib)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Bergamo, Italy
  • +16 more
Jan 17, 2023

18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Gland Carcinoma
  • +2 more
  • Computed Tomography
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Breast Cancer, Prostate Cancer, Brain Tumor Trial in Beijing (68Ga-RM26-RGD, 18F-FDG, 68Ga-RM26)

Recruiting
  • Breast Cancer
  • +3 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 18, 2022

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023